Estrella Immunopharma
ESLA
ESLA
6 hedge funds and large institutions have $166K invested in Estrella Immunopharma in 2024 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 3 increasing their positions, reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
6
Holders Change
-1
Holders Change %
-14.29%
% of All Funds
0.09%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
3
Reduced
–
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
TRCT
Tower Research Capital (TRC)
New York
|
$6.91K |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
$70.4K |
| 3 |
Wells Fargo
San Francisco,
California
|
$92 |
Top Sellers
| 1 |
UBS Group
Zurich,
Switzerland
|
$0 |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
1
Geode Capital Management
Boston,
Massachusetts
| $70.4K | +$2.42K | +1,999 | +4% |
|
|
ASM
2
ATW SPAC Management
New York
| $49.6K | – | – | – |
|
|
HHGC
3
Hunting Hill Global Capital
New York
| $26.5K | – | – | – |
|
|
MCP
4
Maso Capital Partners
Hong Kong
| $12K | – | – | – |
|
|
TRCT
5
Tower Research Capital (TRC)
New York
| $6.91K | +$6.12K | +4,939 | +781% |
|
|
6
Wells Fargo
San Francisco,
California
| $92 | +$1 | +1 | +1% |
|
|
7
UBS Group
Zurich,
Switzerland
| – | -$336 | -303 | Closed |
|